Schema-agnostic progressive entity resolution

Entity Resolution (ER) is the task of finding entity profiles that correspond to the same real-world entity. Progressive ER aims to efficiently resolve large datasets when limited time and/or computational resources are available. In practice, its goal is to provide the best possible partial solution by approximating the optimal comparison order of the entity profiles. So far, Progressive ER has only been examined in the context of structured (relational) data sources, as the existing methods rely on schema knowledge to save unnecessary comparisons: they restrict their search space to similar entities with the help of schema-based blocking keys (i.e., signatures that represent the entity profiles). As a result, these solutions are not applicable in Big Data integration applications, which involve large and heterogeneous datasets, such as relational and RDF databases, JSON files, Web corpus etc. To cover this gap, we propose a family of schema-agnostic Progressive ER methods, which do not require schema information, thus applying to heterogeneous data sources of any schema variety. First, we introduce two na\uefve schema-agnostic methods, showing that straightforward solutions exhibit a poor performance that does not scale well to large volumes of data. Then, we propose four different advanced methods. Through an extensive experimental evaluation over 7 real-world, established datasets, we show that all the advanced methods outperform to a significant extent both the na\uefve and the state-of-the-art schema-based ones. We also investigate the relative performance of the advanced methods, providing guidelines on the method selection

Role of cellular senescence and NOX4-mediated oxidative stress in systemic sclerosis pathogenesis.

Systemic sclerosis (SSc) is a systemic autoimmune disease characterized by progressive fibrosis of skin and numerous internal organs and a severe fibroproliferative vasculopathy resulting frequently in severe disability and high mortality. Although the etiology of SSc is unknown and the detailed mechanisms responsible for the fibrotic process have not been fully elucidated, one important observation from a large US population study was the demonstration of a late onset of SSc with a peak incidence between 45 and 54 years of age in African-American females and between 65 and 74 years of age in white females. Although it is not appropriate to consider SSc as a disease of aging, the possibility that senescence changes in the cellular elements involved in its pathogenesis may play a role has not been thoroughly examined. The process of cellular senescence is extremely complex, and the mechanisms, molecular events, and signaling pathways involved have not been fully elucidated; however, there is strong evidence to support the concept that oxidative stress caused by the excessive generation of reactive oxygen species may be one important mechanism involved. On the other hand, numerous studies have implicated oxidative stress in SSc pathogenesis, thus, suggesting a plausible mechanism in which excessive oxidative stress induces cellular senescence and that the molecular events associated with this complex process play an important role in the fibrotic and fibroproliferative vasculopathy characteristic of SSc. Here, recent studies examining the role of cellular senescence and of oxidative stress in SSc pathogenesis will be reviewed

Investigation and monitoring to model the interaction between the Scrovegni’s Chapel in Padova (Italy) and the underlying foundation soil

In Padova's historic centre lies the renowned Scrovegni’s Chapel, painted by Giotto in 1303. The local subsoil primarily consists of silty sand with some layers of silt. The crypt beneath acts as a buffer against soil moisture, preventing damage to the frescoes. However, during heavy rain, groundwater rises flowing across the floor and lateral walls, therefore flooding the pavement. A pumping system is eventually activated to mitigate the pavement inundation. Several investigations including geophysical surveys, piezocone tests, and boreholes with soil sampling have been conducted to provide the subsoil geotechnical model and understand the local hydrogeological behaviour. Monitoring systems, such as piezometers, deep extensometers and optical fiber cables, track groundwater levels and long-term soil displacements. The paper aims to characterize the subsoil's stratigraphy, mechanical properties and permeabilities to model how the environmental conditions affect the ancient Chapel and ensure its long-term stability

Kawasaki disease in infants less than one year of age : An Italian cohort from a single center

Background and aims Few data are currently available for Kawasaki disease (KD) below 12 months especially in Caucasians. This study aims to analyze clinical and laboratory features of KD among an Italian cohort of infants. Methods A retrospective chart review of KD children aged less than 1 year at time of disease onset between January 2008-December 2017 was performed. Clinical data, laboratory parameters, instrumental findings, treatment and outcome were collected in a customized database. Results Among 113 KD patients, 32 (28.3%) were younger than 1 year. Nineteen patients aged below 6 months, and three below 3 months. The median age was 5.7 +/- 2.7 months. The mean time to diagnosis was 7 +/- 3 days and was longer in the incomplete forms (8 +/- 4 vs 6 +/- 1 days). Conjunctival injection was present in 26 patients (81.2%); rash in 25 (78.1%); extremity changes in 18 (56.2%); mucosal changes in 13 (40.6%,) and lymphadenopathy only in 7 (21.8%). Mucosal changes were the least common features in incomplete forms (18.2%). Twenty-two patients (68.7%) had incomplete KD. Nineteen (59.4%) had cardiac involvement, of whom 13 (59.0%) had incomplete form. ESR, PCR and platelet values were higher in complete KD; especially, ESR resulted significantly higher in complete forms (80 +/- 25.7 mm/h vs 50 +/- 28.6 mm/h; p = 0.01). Conversely, AST level was statistically significant higher in patients with incomplete forms (95.4 +/- 132.7 UI/L vs 29.8 +/- 13.2 UI/L; p = 0.03). All patients received IVIG. Response was reported in 26/32 patients; 6 cases needed a second dose of IVIG and one required a dose of anakinra. Conclusion In our cohort, incomplete disease was commonly found, resulting in delayed diagnoses and poor cardiac prognosis. Infants with incomplete KD seem to have a more severe disease and a greater predilection for coronary involvement than those with complete KD. AST was significantly higher in incomplete forms, thus AST levels might be a new finding in incomplete forms' diagnosis. Eventually, we highlight a higher resistance to IVIG treatment. To our knowledge this is the first study involving an Italian cohort of patients with KD below 12 months

The landscape of cognitive impairment in superoxide dismutase 1-amyotrophic lateral sclerosis

Although mutations in the superoxide dismutase 1 gene account for only a minority of total amyotrophic lateral sclerosis cases, the discovery of this gene has been crucial for amyotrophic lateral sclerosis research. Since the identification of superoxide dismutase 1 in 1993, the field of amyotrophic lateral sclerosis genetics has considerably widened, improving our understanding of the diverse pathogenic basis of amyotrophic lateral sclerosis. In this review, we focus on cognitive impairment in superoxide dismutase 1-amyotrophic lateral sclerosis patients. Literature has mostly reported that cognition remains intact in superoxide dismutase 1-amyotrophic lateral sclerosis patients, but recent reports highlight frontal lobe function frailty in patients carrying different superoxide dismutase 1-amyotrophic lateral sclerosis mutations. We thoroughly reviewed all the various mutations reported in the literature to contribute to a comprehensive database of superoxide dismutase 1-amyotrophic lateral sclerosis genotype-phenotype correlation. Such a resource could ultimately improve our mechanistic understanding of amyotrophic lateral sclerosis, enabling a more robust assessment of how the amyotrophic lateral sclerosis phenotype responds to different variants across genes, which is important for the therapeutic strategy targeting genetic mutations. Cognition in superoxide dismutase 1-amyotrophic lateral sclerosis deserves further longitudinal research since this peculiar frailty in patients with similar mutations can be conditioned by external factors, including environment and other unidentified agents including modifier genes